.png?auto=format&fit=max&auto=format&fit=max&w=1600)
Clarity Beyond the Initial Diagnosis
The Oncotype DX Breast Recurrence Score ® test is a personalized test performed on tumor tissue that estimates the risk of distant recurrence —and helps predict if patients may benefit from chemotherapy, regardless of nodal status. The Breast Recurrence Score ® test helps predict chemotherapy benefit in patients with HR+, HER2- early-stage breast cancer, regardless of nodal status.
Products/Services That Might Help In Your Journey
Non-Invasive Cancer Detection
A novel diagnostic modality based on single cell biophysical markers
Multi-Cancer Early Detection Test
A simple blood-based test that analyzes blood for signals from many cancer types
Microbiome Test
GutID’s high-resolution, high-accuracy data reveals the full gut microbiome
Non-Invasive CRC Screening
A noninvasive and effective prescription-based colon cancer screening test